Research article
Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer
-
* Corresponding author: Mark D Pegram mpegram@med.miami.edu
Breast Cancer Research 2009, 11:R73 doi:10.1186/bcr2409
No comments have yet been made on this article.